Since insurance is designed to spread the costs of health care over a large number of people, this means New Yorkers who may never come within a mile of an opioid would pay for the tax through higher insurance premiums. Not only that, but because the state itself purchases so many opioid medicines through Medicaid, New York taxpayers will end up footing the bill for the higher prices. That’s the first loss for New York State.